Is syrup of ipecac still for sale? Comparison of pharmacies in a large urban area - 2003 Versus 2005

Nancy R. Kelly, Sarai H. Sanchez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There has been considerable publicity about the lack of benefit and potential dangers of syrup of ipecac. In November 2003, the American Academy of Pediatrics recommended against its use. Pharmacies in Houston, Texas were surveyed by telephone before (survey 1) and after (survey 2) the American Academy of Pediatrics' recommendation to determine whether ipecac availability changed. There were 126 pharmacies interviewed at survey 1, and 128 interviewed at survey 2. Pharmacies in survey 1 were more likely than those in survey 2 to sell ipecac (79% versus 64%, P <.01) and to have it in stock (75% versus 48%, P <.001). Pharmacies mostly stored ipecac on the shelves (67%, survey 1; 59%, survey 2, P =.27). Although syrup of ipecac availability has declined significantly, it is still available in more than 50% of pharmacies. Health care providers should advise against its use and advocate that pharmacies remove it.

Original languageEnglish (US)
Pages (from-to)320-324
Number of pages5
JournalClinical Pediatrics
Volume46
Issue number4
DOIs
StatePublished - May 2007

Fingerprint

Ipecac
Pharmacies
Pediatrics
Surveys and Questionnaires
Telephone
Health Personnel

Keywords

  • Pharmacies
  • Poisoning
  • Syrup of ipecac

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Is syrup of ipecac still for sale? Comparison of pharmacies in a large urban area - 2003 Versus 2005. / Kelly, Nancy R.; Sanchez, Sarai H.

In: Clinical Pediatrics, Vol. 46, No. 4, 05.2007, p. 320-324.

Research output: Contribution to journalArticle

@article{06342babf52e4bc9bfdc6db813829d3f,
title = "Is syrup of ipecac still for sale? Comparison of pharmacies in a large urban area - 2003 Versus 2005",
abstract = "There has been considerable publicity about the lack of benefit and potential dangers of syrup of ipecac. In November 2003, the American Academy of Pediatrics recommended against its use. Pharmacies in Houston, Texas were surveyed by telephone before (survey 1) and after (survey 2) the American Academy of Pediatrics' recommendation to determine whether ipecac availability changed. There were 126 pharmacies interviewed at survey 1, and 128 interviewed at survey 2. Pharmacies in survey 1 were more likely than those in survey 2 to sell ipecac (79{\%} versus 64{\%}, P <.01) and to have it in stock (75{\%} versus 48{\%}, P <.001). Pharmacies mostly stored ipecac on the shelves (67{\%}, survey 1; 59{\%}, survey 2, P =.27). Although syrup of ipecac availability has declined significantly, it is still available in more than 50{\%} of pharmacies. Health care providers should advise against its use and advocate that pharmacies remove it.",
keywords = "Pharmacies, Poisoning, Syrup of ipecac",
author = "Kelly, {Nancy R.} and Sanchez, {Sarai H.}",
year = "2007",
month = "5",
doi = "10.1177/0009922806294069",
language = "English (US)",
volume = "46",
pages = "320--324",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Is syrup of ipecac still for sale? Comparison of pharmacies in a large urban area - 2003 Versus 2005

AU - Kelly, Nancy R.

AU - Sanchez, Sarai H.

PY - 2007/5

Y1 - 2007/5

N2 - There has been considerable publicity about the lack of benefit and potential dangers of syrup of ipecac. In November 2003, the American Academy of Pediatrics recommended against its use. Pharmacies in Houston, Texas were surveyed by telephone before (survey 1) and after (survey 2) the American Academy of Pediatrics' recommendation to determine whether ipecac availability changed. There were 126 pharmacies interviewed at survey 1, and 128 interviewed at survey 2. Pharmacies in survey 1 were more likely than those in survey 2 to sell ipecac (79% versus 64%, P <.01) and to have it in stock (75% versus 48%, P <.001). Pharmacies mostly stored ipecac on the shelves (67%, survey 1; 59%, survey 2, P =.27). Although syrup of ipecac availability has declined significantly, it is still available in more than 50% of pharmacies. Health care providers should advise against its use and advocate that pharmacies remove it.

AB - There has been considerable publicity about the lack of benefit and potential dangers of syrup of ipecac. In November 2003, the American Academy of Pediatrics recommended against its use. Pharmacies in Houston, Texas were surveyed by telephone before (survey 1) and after (survey 2) the American Academy of Pediatrics' recommendation to determine whether ipecac availability changed. There were 126 pharmacies interviewed at survey 1, and 128 interviewed at survey 2. Pharmacies in survey 1 were more likely than those in survey 2 to sell ipecac (79% versus 64%, P <.01) and to have it in stock (75% versus 48%, P <.001). Pharmacies mostly stored ipecac on the shelves (67%, survey 1; 59%, survey 2, P =.27). Although syrup of ipecac availability has declined significantly, it is still available in more than 50% of pharmacies. Health care providers should advise against its use and advocate that pharmacies remove it.

KW - Pharmacies

KW - Poisoning

KW - Syrup of ipecac

UR - http://www.scopus.com/inward/record.url?scp=34247223740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247223740&partnerID=8YFLogxK

U2 - 10.1177/0009922806294069

DO - 10.1177/0009922806294069

M3 - Article

C2 - 17475989

AN - SCOPUS:34247223740

VL - 46

SP - 320

EP - 324

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 4

ER -